Brief: vTv Therapeutics Reports Q3 Loss Per Share Of $0.02
09/11/2021 13:59
Nov 9 (Reuters) - vTv Therapeutics Inc VTVT.O :
* VTV THERAPEUTICS ANNOUNCES 2021 THIRD QUARTER FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE
* Q3 REVENUE $3.0 MILLION
* Q3 LOSS PER SHARE $0.02
Source text for Eikon: ID:nGNX62kRC
Further company coverage: VTVT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on vTv Therapeutics
See all newsBrief: Vtv Therapeutics Announces FDA Orphan Drug Designation For Hppd In Sickle Cell Disease
vTv Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
vTv Therapeutics Inc expected to post a loss of $1.04 a share - Earnings Preview
vTv Therapeutics Q2 net loss widens on higher trial costs
Brief: VTv Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)